Success Metrics

Clinical Success Rate
97.9%

Based on 46 completed trials

Completion Rate
98%(46/47)
Active Trials
0(0%)
Results Posted
2%(1 trials)
Terminated
1(2%)

Phase Distribution

Ph phase_4
5
10%
Ph phase_1
9
19%
Ph phase_2
21
44%
Ph not_applicable
4
8%
Ph phase_3
9
19%

Phase Distribution

9

Early Stage

21

Mid Stage

14

Late Stage

Phase Distribution48 total trials
Phase 1Safety & dosage
9(18.8%)
Phase 2Efficacy & side effects
21(43.8%)
Phase 3Large-scale testing
9(18.8%)
Phase 4Post-market surveillance
5(10.4%)
N/ANon-phased studies
4(8.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

95.8%

46 of 48 finished

Non-Completion Rate

4.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

48

all time

Status Distribution
Completed(46)
Terminated(2)

Detailed Status

Completed46
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
48
Active
0
Success Rate
97.9%
Most Advanced
Phase 4

Trials by Phase

Phase 19 (18.8%)
Phase 221 (43.8%)
Phase 39 (18.8%)
Phase 45 (10.4%)
N/A4 (8.3%)

Trials by Status

withdrawn12%
completed4696%
terminated12%

Recent Activity

Clinical Trials (48)

Showing 20 of 48 trialsScroll for more
NCT00122603Phase 2

Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)

Completed
NCT00056641Phase 2

Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients

Completed
NCT00000891Phase 2

Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315

Completed
NCT00000892Not Applicable

A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Completed
NCT00000848Phase 2

The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year

Completed
NCT00000906Phase 1

Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients

Completed
NCT00005762Not Applicable

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Completed
NCT00102206Phase 2

A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Completed
NCT00001087Phase 2

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Completed
NCT00051831Not Applicable

Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults

Completed
NCT00001108Phase 1

A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses

Completed
NCT00084058Phase 1

Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV

Completed
NCT00000913Phase 2

A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children

Completed
NCT00000941Phase 1

A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood

Completed
NCT00000920Phase 1

Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns

Completed
NCT00000912Phase 2

A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients

Completed
NCT00000898Not Applicable

The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir

Completed
NCT00050180Phase 4

Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers

Completed
NCT00477048Phase 2

Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity

Completed
NCT00001094Phase 2

A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients

Withdrawn

Drug Details

Intervention Type
DRUG
Total Trials
48